NEW YORK, Feb. 4, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Caribou Biosciences, Inc. (“Caribou” or the “Company”) (NASDAQ: CRBU) and certain officers. The class action, filed in the United States District Court for the Northern…
Category: Uncategorized
NEW YORK, Feb. 4, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) (NASDAQ: KYTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or…
NEW YORK, Feb. 4, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against DMC Global Inc. (“DMC” or the “Company”) (NASDAQ: BOOM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW),…
NEW YORK, Feb. 4, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Marqeta, Inc. (“Marqeta” or the “Company”) (NASDAQ: MQ). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW),…
NEW YORK, Feb. 4, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Sun Communities, Inc. (“Sun Communities” or the “Company”) (NYSE: SUI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or…
NEW YORK, Feb. 4, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava” or the “Company”) (NASDAQ: SAVA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or…
NEW YORK, Feb. 4, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Enphase Energy, Inc. (“Enphase” or the “Company”) (NASDAQ: ENPH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or…
NEW YORK, Feb. 4, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ: AZN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Feb. 4, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Innovative Industrial Properties, Inc. (“IIPR”, “IIP”, or the “Company”) (NYSE: IIPR) and certain officers. The class action, filed in the United States District Court for the…
NEW YORK, Feb. 4, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (NASDAQ: WBA) and certain officers. The class action, filed in the United States District Court for the Northern…